HELP
Cybin Inc.
A Canadian clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health conditions such as depression and anxiety. It engineers lab-modified versions of naturally occurring compounds, including psilocybin—the mushroom molecule behind the company's name. Founded in 2019, the firm later rebranded as Helus Pharma, pronounced "heal us."
CUSIP: 23256X407HealthcareCA1 holder
Total Value
$4.90M
Total Shares
598.4K
Net Share Change
+598.4K
Activity
1 buying
Investor
Value
Shares
Weight
Change
